A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors

Clinical trial NCT03267316 · COMPLETED

Trial details

NCT number: NCT03267316
Sponsor: Cantargia AB
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Pancreatic Ductal Adenocarcinoma Triple Negative Breast Cancer Colorectal Cancer

Start date: 2017-09-19
Primary completion: 2024-03-14
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.